William M. Carroll
0000-0002-5088-548X
Publication & Citation Trends
Publications
0 total
Clinician-led, single-blind, randomised controlled trial evaluating the efficacy of a high-intensity resistance and impact training intervention for improving health-related quality of life in people with multiple sclerosis: protocol for STRONG-MS
Cited by 0
Semantic Scholar
Should natalizumab be used despite JC virus positivity? Yes
Cited by 0
Semantic Scholar
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.
Cited by 23
Semantic Scholar
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial
Cited by 0
Semantic Scholar
Low Disease Activity Over 4 Years of Ocrelizumab Therapy in Treatment-naive Patients with High-activity, Early-stage Relapsing-remitting Multiple Sclerosis in the ENSEMBLE Study (P10-6.007)
Cited by 0
Semantic Scholar
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial OA
Cited by 3
Semantic Scholar
Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis OA
Cited by 22
Semantic Scholar
Reflections on 2008
Cited by 6
Semantic Scholar
Research Topics
Multiple Sclerosis Research Studies
(81)
Peripheral Neuropathies and Disorders
(30)
Mathematics Education and Teaching Techniques
(19)
Corrosion Behavior and Inhibition
(19)
Systemic Lupus Erythematosus Research
(15)
Affiliations
University College Dublin
Roosevelt University
Northwestern University
St John of God Subiaco Hospital
Université de Bordeaux